Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lansing Taylor

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Journal of Pathology Informatics|December 21, 2016
Pointwise mutual information quantifies intratumor heterogeneity in tissue sections labeled with multiple fluorescent biomarkersDaniel M Spagnolo, Rekha Gyanchandani, Yousef Al-Kofahi, et al.
Molecular Cancer Research : MCR|April 3, 2020
Targeting NAD<sup>+</sup> Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma ResistanceEsther P Jane, Daniel R Premkumar, Swetha Thambireddy, et al.
Experimental Biology and Medicine (Maywood, N.J.)|April 26, 2014
In vitro platforms for evaluating liver toxicityShyam Sundhar Bale, Lawrence Vernetti, Nina Senutovitch, et al.
Stem Cell Research & Therapy|February 26, 2014
Towards a three-dimensional microfluidic liver platform for predicting drug efficacy and toxicity in humansAbhinav Bhushan, Nina Senutovitch, Shyam S Bale, et al.
Clinical and Translational Science|March 3, 2018
Opportunities and Challenges in Implementation of Multiparameter Single Cell Analysis Platforms for Clinical TranslationSusan M Keating, D Lansing Taylor, Anne L Plant, et al.
Plos One|July 19, 2014
Identifying and quantifying heterogeneity in high content analysis: application of heterogeneity indices to drug discoveryAlbert H Gough, Ning Chen, Tong Ying Shun, et al.
International Journal of Molecular Sciences|June 10, 2023
The Combination of a Human Biomimetic Liver Microphysiology System with BIOLOGXsym, a Quantitative Systems Toxicology (QST) Modeling Platform for Macromolecules, Provides Mechanistic Understanding of Tocilizumab- and GGF2-Induced Liver InjuryJames J Beaudoin, Lara Clemens, Mark T Miedel, et al.
Molecular Systems Biology|August 2, 2021
A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infectionFangyuan Chen, Qingya Shi, Fen Pei, et al.
Oncology|January 8, 2018
Clinically Observed Estrogen Receptor Alpha Mutations within the Ligand-Binding Domain Confer Distinguishable PhenotypesShanhang Jia, Mark T Miedel, Marilyn Ngo, et al.
Experimental Biology and Medicine (Maywood, N.J.)|May 7, 2021
Quantifying the progression of non-alcoholic fatty liver disease in human biomimetic liver microphysiology systems with fluorescent protein biosensorsManush Saydmohammed, Anupma Jha, Vineet Mahajan, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Journal of Pathology Informatics|December 21, 2016
Pointwise mutual information quantifies intratumor heterogeneity in tissue sections labeled with multiple fluorescent biomarkersDaniel M Spagnolo, Rekha Gyanchandani, Yousef Al-Kofahi, et al.
Molecular Cancer Research : MCR|April 3, 2020
Targeting NAD<sup>+</sup> Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma ResistanceEsther P Jane, Daniel R Premkumar, Swetha Thambireddy, et al.
Experimental Biology and Medicine (Maywood, N.J.)|April 26, 2014
In vitro platforms for evaluating liver toxicityShyam Sundhar Bale, Lawrence Vernetti, Nina Senutovitch, et al.
Stem Cell Research & Therapy|February 26, 2014
Towards a three-dimensional microfluidic liver platform for predicting drug efficacy and toxicity in humansAbhinav Bhushan, Nina Senutovitch, Shyam S Bale, et al.
Clinical and Translational Science|March 3, 2018
Opportunities and Challenges in Implementation of Multiparameter Single Cell Analysis Platforms for Clinical TranslationSusan M Keating, D Lansing Taylor, Anne L Plant, et al.
Plos One|July 19, 2014
Identifying and quantifying heterogeneity in high content analysis: application of heterogeneity indices to drug discoveryAlbert H Gough, Ning Chen, Tong Ying Shun, et al.
International Journal of Molecular Sciences|June 10, 2023
The Combination of a Human Biomimetic Liver Microphysiology System with BIOLOGXsym, a Quantitative Systems Toxicology (QST) Modeling Platform for Macromolecules, Provides Mechanistic Understanding of Tocilizumab- and GGF2-Induced Liver InjuryJames J Beaudoin, Lara Clemens, Mark T Miedel, et al.
Molecular Systems Biology|August 2, 2021
A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infectionFangyuan Chen, Qingya Shi, Fen Pei, et al.
Oncology|January 8, 2018
Clinically Observed Estrogen Receptor Alpha Mutations within the Ligand-Binding Domain Confer Distinguishable PhenotypesShanhang Jia, Mark T Miedel, Marilyn Ngo, et al.
Experimental Biology and Medicine (Maywood, N.J.)|May 7, 2021
Quantifying the progression of non-alcoholic fatty liver disease in human biomimetic liver microphysiology systems with fluorescent protein biosensorsManush Saydmohammed, Anupma Jha, Vineet Mahajan, et al.
Pageof 8